BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/25/2023 8:26:33 AM | Browse: 390 | Download: 1507
Publication Name World Journal of Clinical Cases
Manuscript ID 86327
Country China
ISSN 2307-8960 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Case Report
Article Title Rare ROS1-CENPW gene in pancreatic acinar cell carcinoma and the effect of crizotinib plus AG chemotherapy: A case report
Manuscript Source Unsolicited Manuscript
All Author List Tao Wang and Yi-Yu Shen
ORCID
Author(s) ORCID Number
Tao Wang http://orcid.org/0009-0005-5741-0267
Yi-Yu Shen http://orcid.org/0000-0002-4454-4275
Funding Agency and Grant Number
Corresponding Author Yi-Yu Shen, MCh, Chief Physician, Doctor, Doctor, Surgeon, Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Jiaxing University, No. 1518 Huancheng North Road, Jiaxing 314051, Zhejiang Province, China. syjdr@163.com
Key Words ROS1-CENPW; Pancreatic acinar cell carcinoma; Crizotinib; Gemcitabine; Albumin paclitaxel; Case report
Core Tip ROS1-CENPW is a novel fusion gene locus in pancreatic acinar cell carcinoma that has not been previously reported. We detected this rare fusion gene in a 77-year-old female patient with pancreatic acinar cell carcinoma. We adopted the treatment regimen of crizotinib combined with AG chemotherapy (gemcitabine 1000 mg/m2 plus albumin paclitaxel 125 mg/m2). A good therapeutic effect was achieved.
Publish Date 2023-08-25 08:26
Citation Wang T, Shen YY. Rare ROS1-CENPW gene in pancreatic acinar cell carcinoma and the effect of crizotinib plus AG chemotherapy: A case report. World J Clin Cases 2023; 11(24): 5823-5829
URL https://www.wjgnet.com/2307-8960/full/v11/i24/5823.htm
DOI https://dx.doi.org/10.12998/wjcc.v11.i24.5823
Full Article (PDF) WJCC-11-5823-with-cover.pdf
Full Article (Word) WJCC-11-5823.docx